GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rize Oncology Inc (XCNQ:RIZE) » Definitions » Other Assets for Insurance Companies

Rize Oncology (XCNQ:RIZE) Other Assets for Insurance Companies


View and export this data going back to 2022. Start your Free Trial

What is Rize Oncology Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Rize Oncology Business Description

Industry
Traded in Other Exchanges
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3
Rize Oncology Inc is is a biopharmaceutical company. The company is focused on the development of high-efficiency precision gene editing for human therapeutics applications. The company is also engaged in oncology, particularly soft tissue sarcoma, introduced by the recent exclusive licensing of STS-201, delivering small molecules targeting soft tissue sarcoma and other cancers.
Executives
William James Garner 10% Security Holder, Director
Andre Pereira Fraga Figueiredo Director